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Effects of a herbal compound
containing bupleurum on human
lymphocytes
Bupleurum-containing compounds, such as KY88 Liver Livo are
thought to have immunomodulatory effects. This study investi-
gated the effects of KY88 Liver Livo on the mitogenic induction of
lymphocytes in vitro. Fifteen healthy human adult volunteers, aged
between 20 and 50 years, provided peripheral blood samples from
which lymphocytes were obtained by Ficoll-Hypaque centrifugation.
The separated lymphocytes were stimulated by phytohaemagglutinin
and KY88 Liver Livo in varying concentrations for 72 hours,
with greater cluster and colony formation evident compared with
lymphocytes in a control preparation. KY88 Liver Livo was also found
to induce the secretion of granulocyte-macrophage colony-stimulating
factor in a dose-dependent fashion. These preliminary in vitro studies
suggest that KY88 Liver Livo may have potential clinical value in the
treatment of chronic viral infection and in the management of
immunocompromised patients.
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Introduction
Traditional herbal medicine has been used in China since the first
century BC. Thereafter, traditional herbal products have been improved
on an individual basis. Although still mainly used by Chinese, traditional
herbal medicine is gaining acceptance among patients outside China.1,2
The search for effective drugs has also prompted researchers to investigate
the efficacy of natural products as medicines. The medicinal properties of
the Camptotheca acuminata and the bark of the pacific yew tree (Taxus),
have been known to the Chinese for a lengthy period. However, it was
only in the 1960s that these substances were discovered by the US
National Cancer Institute to have anticancer properties. Despite such
findings, herbal medicine is not mainstream therapy and is often
categorised as a form of complementary or alternative medicine.3
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Currently, most herbal medicine is made into tablets
and ingested as a form of drug therapy. Almost all
herbal medicine is heterogeneous in nature, comprised
of a complex mixture of extracts in a given ratio. The
final products, therefore, cannot be characterised easily,
or their active substances well defined. The quality and
safety of the products is dependent on the processing/
collection of source materials and the manufacturing
process.
Traditional herbal medicine uses a compound
formulary approach—rather than a simple arithmetic
sum of the effect of each individual ingredient—which
is considered essential to the medicine’s action. This
is described in ‘Shen Nong Ben Cao Jin’, one of the
earliest Chinese pharmacopoeia known today, which
is thought to have been compiled during the Eastern
Han Dynasty, based on the written records of herbalists
in earlier centuries. Within the therapeutic herbal
compound, some herbs treat the disease, some reduce
the side-effects, and the remaining act to ‘fuse’ and
deliver the medicine to targets within the body. This
approach makes use of the synergistic effects of herbs
to act at different molecular channels and hence achieve
the intended function. Clinical experience in China
indicates that such an approach is effective.
Chinese herbal medicine is used regularly by
practitioners for ‘modulating immunity’. Experiments
on Imperata cylindrica (Beauv) and other purified
polysaccharides have demonstrated that these
substances are excellent immunomodulating agents.
Polysaccharides or saponins have been shown to
stimulate macrophages, promote antibody formation,
activate complement, and increase T-lymphocyte
proliferation.4 Other herbs, such as Tripterygium
wilfordii, Aconitum, and Artemisiae spp have
apparent immunosuppressive effects. Some of these
herbal medicines are now used clinically for the
treatment of rheumatoid arthritis, chronic nephritis,
systemic lupus erythematosis, and various skin
disorders.
Bupleurum-containing compounds are known to
possess anti-inflammatory effects. KY88 Liver Livo
(Hon Ding International Ltd, Hong Kong, China) is
one such compound, used by Chinese medicine
practitioners in the treatment of acute and chronic
hepatitis B virus (HBV) infection. It is believed to effect
elimination of HBV, strengthening the immune system,
and stimulating liver cell regeneration. This study aims
to evaluate its action on the mitogenic stimulation of
lymphocyte proliferation.
Materials and methods
KY88 Liver Livo preparation
The ingredients of KY88 Liver Livo are: Schizandrae
fructus, Bupleuri radix, Artemisiae capillaris,
Desmodii herba, Poria sclerotium, Lithospermi radix,
Paeoniae radix, Phellodendri cortex, Scutellariae
radix, and Trichosanthis radix.
KY88 Liver Livo (50 g) was extracted with
methanol (500 mL x 3). The solid residue of the crude
extract was then dissolved in dimethyl sulphoxide to a
concentration of 92 mg/mL and stored at 4°C until use.
For use, the KY88 Liver Livo was diluted (10 mg/mL)
in Hank’s Balanced Salt Solution (HBSS) [Invitrogen,
Carlsbad, California, US] and filtered using 0.22 Micro
Cellulose Acetate (Corning, New York, US) for
sterilisation.
Subject selection
Fifteen healthy adults, aged from 20 to 50 years were
recruited for the study. Written consent was obtained
from each participant and 30 mL of peripheral venous
blood subsequently collected from each subject and
placed in sterilised tubes containing heparin.
Lymphocyte isolation and culture
The blood samples were centrifuged at 1200
revolutions per minute (rpm) at room temperature for
10 minutes. Cells were collected and mixed thoroughly
with ice cold HBSS containing 10 mM Hepes (Sigma,
St Louis, US). The samples were carefully layered over
Ficoll Hypaque (Pharmacia, Uppsala, Sweden) and
centrifuged at 2000 rpm for 20 minutes at 4°C.
Peripheral blood mononuclear cells were isolated and
the interface was harvested and washed three times
with cold Roswell Park Memorial Institute (RPMI)
1640 medium (serum free).
The isolated cells were cultured in RPMI 1640
medium mixed with 10% deactivated foetal bovine
serum, 10 mM Hepes, and 1% antibiotics (100 µg/mL
penicillin and 100 µg/mL streptomycin) in an incubator
at 37°C with 5% carbon dioxide.
After overnight incubation, the separated lympho-
cytes were stimulated with 10 µg/mL phytohaemag-
glutinin (PHA) (Roche, Sandhofer, Strasse, Germany),
and 0.1 µg/mL, 1 µg/mL, or 10 µg/mL concentrations
of KY88 Liver Livo for 72 hours. The optimal
concentrations of KY88 Liver Livo were calculated
according to the recommended dosage from the
supplier. Roswell Park Memorial Institute 1640
medium only was added to one culture as a control.
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Proliferation assay for KY88 Liver Livo
Proliferation of lymphocytes was assessed with the
cell proliferation reagent WST1 assay (Boehringer
Mannheim, Mannheim, Germany). The lymphocytes
were cultured at a density of 4000 cells per well
into 96-well microtitre plates (Costar, Cambridge,
Massachusetts, US) and incubated at 37°C for 24
hours. This cell number was chosen to maintain the
cells in an exponential growth phase throughout the
experiment, and to allow measurement of optical
density at the linear portion of the curves. KY88 Liver
Livo was serially diluted with culture medium and
different concentrations were added to the plates after
24 hours at a volume of 200 µL per well. The cells
were incubated and harvested after 72 hours of culture.
At the time of harvest, 10 µL of WST1 was mixed
with 100 µL of medium. The mixture was added to
each well and the incubation was continued for another
2.5 hours at 37°C. The optical density was read at
540 nm on a spectrophotometer (Bio-Tek Universal
Microplate Reader, ELX 800, Winooski, Vermont, US).
Cyto-preparation
After 72-hours’ incubation, the cell suspensions were
adjusted to 5 x 105 cells/mL in 1 mM phosphate-
buffered saline (PBS). Aliquots of 50 µL of the cell
suspension were loaded into cuvettes and centrifuged
at 2000 rpm for 10 minutes onto a DAKO silanized
slide (DAKO, Glostrup, Denmark) in a Cytospin
cytocentrifuge (Wescor, Logan, Utah, US). The slides
were fixed for 10 minutes in acetone and washed
three times with 1 mM PBS. The peripheral blood
mononuclear cells were stained with hematoxylin for
3 minutes and eosin for 5 minutes. The finished slides
were observed under interference contrast micro-
scope using the Coolsnap Capture system (Roper
Scientific Inc., Arizona, US) with 200x magnification.
The colonies were measured by an Image Analysor
(Metamorph-Winshell, Universal Imaging Corpo-
ration, Pennsylvania, US).
Scoring of lymphocyte cluster and colonies
The scoring of colonies utilised was adapted from the
system described by Lange.5 In brief, aggregates of 3-20
cells were regarded as clusters and aggregates of over 50
cells considered colonies. The area of each colony was
marked out and measured using the accompanying
software of the Image Analysor. The mean total area in
mm2 was used for statistical calculation.
Determinations of granulocyte-macrophage
colony-stimulating factor level
Granulocyte-macrophage colony-stimulating factor
(GM-CSF) was measured in the supernatant of the
culture system. The lymphocytes were cultured
according to the above method. After incubation, the
supernatants were harvested and stored at -70°C until
analysis. Granulocyte-macrophage colony-stimulating
factor concentrations were determined using an
enzyme-linked immunosorbent assay (ELISA)
commercial kit (Intergen, New York, US). The
procedure was performed according to the manu-
facturer’s instructions.
Statistical analysis
All values were expressed as a mean and standard error
of mean unless otherwise stated. Parameters were
compared using the Statistical Package for Social
Sciences (Windows version 6.0; SPSS Inc., Chicago,
US). The parameters were evaluated using the paired
samples t-test. A P value of 0.05 or less was taken as
statistically significant.
Results
Lymphocytes were seen to proliferate in response to
the stimulation from PHA and KY88 Liver Livo. The
proliferation rate as measured by WST1 was greatest
when the lymphocytes were stimulated with KY88
Liver Livo at a concentration of 0.1 µg/mL. The rate
of proliferation decreased progressively with increasing
KY88 Liver Livo concentration (Fig 1). The lympho-
cyte proliferation rates for KY88 Liver Livo concen-
trations of 0.1 µg/mL and 1 µg/mL were significantly
different from that of the control group (P<0.001 and
P=0.048, respectively).
Lymphocytes tended to form clusters and colonies
after stimulation. The number of clusters and col-
onies was determined according to Lange’s method.5
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Fig 1. Lymphocyte proliferation after stimulation with
phytohaemagglutinin (10 µg/mL) and KY88 Liver Livo
in different concentrations
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Lymphocytes in the control culture were scattered and
demonstrated no ability to form a colony (Fig 2a).
However, lymphocyte colony formation was evident
after the addition of PHA (Fig 2b) and KY88 Liver
Livo (Figs 2c to 2e). Although the number of clusters
was similar between the control and test cultures, the
number of colonies in the test cultures was significantly
greater than the control group. The respective P values
were 0.016, 0.044, and 0.037 for KY88 Liver Livo at
concentrations of 0.1 µg/mL, 1 µg/mL, and 10 µg/mL of
KY88 Liver Livo. The number of colonies were similar
in PHA and KY88 Liver Livo cultures (Fig 3). The total
area of lymphocyte clusters and colonies was also
measured. The mean area of the clusters did not differ
significantly between the control culture and the test
cultures. However, PHA and KY88 Liver Livo induced
significant differences in mean colony size compared
with the control group (Fig 4). The P values derived
were <0.001, 0.002, 0.03, and 0.05 for PHA, and KY88
Liver Livo concentrations of 0.1 µg/mL, 1 µg/mL, and
10 µg/mL, respectively. There were no statistically
significant differences seen between the different
KY88 Liver Livo concentrations in this regard.
The production of GM-CSF was minimal in the
control culture, whereas KY88 Liver Livo and PHA
induced significant production of GM-CSF (Fig 5). The
levels of GM-CSF show a linear relation with the
different concentrations of KY88 Liver Livo used. The
levels were six, eight and 12 times higher than that of
Fig 2. Light microscopy (104.4x) showing human
lymphocyte colony formation in different preparations
(a) The control group showed no ability to form colonies; (b)
Lymphocytes formed the largest colonies after stimulation
with phytohaemagglutinin; and (c-e) Lymphocytes
demonstrated similar colony formation ability after
stimulation with differing concentrations of KY88 Liver Livo
a. b.
c. d.
e.
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the control group when the lymphocytes were stimulated
with KY88 Liver Livo at concentrations of 0.1 µg/mL,
1 µg/mL, and 10 µg/mL. The P values derived were
0.166, 0.047, and 0.003, respectively.
Discussion
The herbal compound formulation approach for
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Fig 3. Lymphocyte proliferation: cluster and colony
formation in differing preparations after 72 hours
Significant differences were detected between the mean
number of colonies in the phytohaemagglutinin and KY 88
Liver Livo preparations and the control preparation (P<0.05
for all comparisons)
Fig 4. Lymphocyte proliferation: colony size in differing
preparations after 72 hours
Significant differences in colony size were seen in the
phytohaemagglutinin and KY 88 Liver Livo preparations
compared to the control preparation
Fig 5. Production of granulocyte-macrophage colony-
stimulating factor by human lymphocytes in differing
preparations after 72 hours
Phytohaemagglutinin and KY88 Liver Livo induced increased
production of granulocyte-macrophage colony-stimulating
factor
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chronic hepatitis therapy aims to eliminate the HBV,
strengthen the immune system, and induce regeneration
of the liver. While this study has not demonstrated that
KY88 Liver Livo is able to eliminate the HBV, it does
indicate that the compound appears to enhance the
immune system, specifically demonstrating that it
stimulates lymphocyte proliferation in vitro.
Although the formation of lymphocyte clusters was
common, even in the control culture, lymphocyte
colonies were seen to form only in response to stimu-
lation. KY88 Liver Livo at the lowest concentration of
0.1 µg/mL was seen to induce a similar number of
colonies compared with other concentrations. Size of
the colonies varied, and therefore error in interpretation
may still occur if only the number of colonies is
considered. With respect to the total area of the colonies,
PHA was noted to have a greater ability to induce
lymphocyte proliferation as determined by the mean total
lymphocyte colony area. There was no significant
difference between KY88 Liver Livo stimulation at
differing concentrations, indicating that the induction
of lymphocyte proliferation with KY88 Liver Livo
occurs irrespective of the concentration used.
This study has demonstrated that the mitogenic
action of KY88 Liver Livo is coupled with the pro-
duction of GM-CSF by lymphocytes. The level of
GM-CSF secretion was related to the concentration of
KY88 Liver Livo used. A linear relation between the
level of GM-CSF production and the KY88 Liver
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Livo concentration was seen, with GM-CSF production
12 times higher than that of the control group when KY88
Liver Livo at a concentration of 10 µg/mL was used.
It is possible that the formation of colonies is related
to the release of GM-CSF.6 This could be determined
by adding neutralisation antibodies against GM-CSF
to the culture system. A decrease in colony formation
would support this hypothesis.6 Other investigators
have reported that the secretion of cytokines is time-
dependent, with secretion levels significantly increased
with a longer period of culture.7 These researchers also
found that a high concentration of a herbal extract did
not produce the same augmentative effect as a low
concentration. This study does confirm that a longer
reaction time is required for significant secretion
of GM-CSF to be noted. However, the secretion of
GM-CSF was found to be concentration dependent,
implying that different compositions of herbal extracts
would tend to produce different effects, even at similar
culture conditions.
Granulocyte-macrophage colony-stimulating
factor is produced by a number of cells, including
lymphocytes and monocytes,8-10 and has a broad
impact on haematopoiesis. Its production is triggered
by exposure to bacterial lipopolysaccharides, activating
the host inflammatory response to invading patho-
gens.11-13 Granulocyte-macrophage colony-stimulating
factor induces the proliferation of monocytes and
macrophages, enhances neutrophil survival and
phagocytosis,14,15 and stimulates committed stem cells
to mature and develop. Low doses induce the formation
of macrophage colonies, whereas high doses induce
the formation of myeloid colonies.16
This study provides insights into the mechanism
of action of KY88 Liver Livo. Knowledge on this
subject is limited, although KY88 Liver Livo is
believed to be effective against the HBV. While KY88
Liver Livo may act on the virus directly, activation of
the host inflammatory response is certainly an import-
ant means of combating viral infection. This study
suggests potential new areas of research into the
treatment of chronic viral infection. It has demonstrated
that properly manufactured herbal medicine is effective
in inducing lymphocyte proliferation and the secretion
of GM-CSF, which is linked to the host inflammatory
response against pathogens. Further clinical evaluation
of this herbal compound would appear worthwhile.
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